{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:25:57Z","timestamp":1788978357421,"version":"build-2803163510"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T00:00:00Z","timestamp":1323388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028915","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T21:54:56Z","timestamp":1323467696000},"page":"e28915","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Rosiglitazone Inhibits Transforming Growth Factor-\u03b21 Mediated Fibrogenesis in ADPKD Cyst-Lining Epithelial Cells"],"prefix":"10.1371","volume":"6","author":[{"given":"Yawei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,12,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease.","volume":"369","author":"VE Torres","year":"2007","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease.","volume":"60","author":"PC Harris","year":"2009","journal-title":"Annu Rev Med"},{"key":"ref3","article-title":"Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases.","volume":"55","author":"VE Torres","year":"2006","journal-title":"Nat Clin Pract Nephrol 2: 40-55; quiz"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1681\/ASN.V381442","article-title":"Autosomal dominant polycystic kidney disease.","volume":"3","author":"JC Lieske","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2734","article-title":"Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.","volume":"222","author":"S Hassane","year":"2010","journal-title":"J Pathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1755.2000.00205.x","article-title":"Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation.","volume":"58","author":"H Okada","year":"2000","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/ndt\/gfl071","article-title":"Gene profiling of polycystic kidneys.","volume":"21","author":"G Schieren","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/ki.1997.190","article-title":"TGF-beta in kidney fibrosis: a target for gene therapy.","volume":"51","author":"WA Border","year":"1997","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1097\/01.ASN.0000033611.79556.AE","article-title":"TGF-beta signaling in renal disease.","volume":"13","author":"EP Bottinger","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1359-6101(99)00025-8","article-title":"TGF-beta signaling by Smad proteins.","volume":"11","author":"K Miyazono","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"22368","DOI":"10.1074\/jbc.271.37.22368","article-title":"Altered transforming growth factor signaling in epithelial cells when ras activation is blocked.","volume":"271","author":"MT Hartsough","year":"1996","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response.","volume":"18","author":"A Leask","year":"2004","journal-title":"FASEB J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"14466","DOI":"10.1074\/jbc.M005724200","article-title":"Transcriptional cross-talk between Smad, ERK1\/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.","volume":"276","author":"H Watanabe","year":"2001","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/emboj\/18.5.1345","article-title":"TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway.","volume":"18","author":"BA Hocevar","year":"1999","journal-title":"EMBO J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"F495","DOI":"10.1152\/ajprenal.2001.280.3.F495","article-title":"Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway.","volume":"280","author":"BY Chin","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3349\/ymj.2009.50.1.105","article-title":"TGF-beta mediated epithelial-mesenchymal transition in autosomal dominant polycystic kidney disease.","volume":"50","author":"SW Chea","year":"2009","journal-title":"Yonsei Med J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks.","volume":"18","author":"X Song","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0272-6386(12)80338-6","article-title":"Aberrant epithelial cell growth in autosomal dominant polycystic kidney disease.","volume":"17","author":"PD Wilson","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00041433-199706000-00006","article-title":"Peroxisome proliferator-activated receptors, orphans with ligands and functions.","volume":"8","author":"K Schoonjans","year":"1997","journal-title":"Curr Opin Lipidol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/endo.135.2.8033830","article-title":"Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation.","volume":"135","author":"A Chawla","year":"1994","journal-title":"Endocrinology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.","volume":"47","author":"BM Spiegelman","year":"1998","journal-title":"Diabetes"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1046\/j.1523-1755.2000.00418.x","article-title":"Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion.","volume":"58","author":"KJ McCarthy","year":"2000","journal-title":"Kidney Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s101570300003","article-title":"Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)gamma activators.","volume":"7","author":"K Haraguchi","year":"2003","journal-title":"Clin Exp Nephrol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.2001.0590051899.x","article-title":"Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.","volume":"59","author":"LJ Ma","year":"2001","journal-title":"Kidney Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/labinvest.2008.104","article-title":"PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta.","volume":"89","author":"T Kawai","year":"2009","journal-title":"Lab Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/CS20100113","article-title":"Rosiglitazone attenuates development of polycystic kidney disease and prolongs survival in Han:SPRD rats.","volume":"119","author":"B Dai","year":"2010","journal-title":"Clin Sci (Lond)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"F465","DOI":"10.1152\/ajprenal.00460.2010","article-title":"PPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.","volume":"300","author":"D Yoshihara","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1046\/j.1523-1755.2002.00277.x","article-title":"Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro.","volume":"61","author":"RE Routh","year":"2002","journal-title":"Kidney Int"},{"key":"ref29","first-page":"62641","article-title":"Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts.","author":"W Wang","year":"2007","journal-title":"Mediators Inflamm"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ki.1984.28","article-title":"Tissue culture of human kidney epithelial cells of proximal tubule origin.","volume":"25","author":"CJ Detrisac","year":"1984","journal-title":"Kidney Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"F397","DOI":"10.1152\/ajprenal.00310.2002","article-title":"Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.","volume":"285","author":"M Loghman-Adham","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00441-007-0521-4","article-title":"Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures.","volume":"331","author":"G Elberg","year":"2008","journal-title":"Cell Tissue Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jcp.1041500220","article-title":"Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia.","volume":"150","author":"PD Wilson","year":"1992","journal-title":"J Cell Physiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1.","volume":"17","author":"S Shibazaki","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbrc.2009.05.084","article-title":"The linker region of Smad2 mediates TGF-beta-dependent ERK2-induced collagen synthesis.","volume":"386","author":"F Li","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/sj.onc.1202521","article-title":"Cross-talk between the Smad1 and Ras\/MEK signaling pathways for TGFbeta.","volume":"18","author":"J Yue","year":"1999","journal-title":"Oncogene"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJMe1006925","article-title":"mTOR inhibitors in polycystic kidney disease.","volume":"363","author":"T Watnick","year":"2010","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ki.2010.250","article-title":"Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease.","volume":"78","author":"I Zafar","year":"2010","journal-title":"Kidney Int"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease.","volume":"363","author":"G Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.","volume":"363","author":"AL Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1523-1755.2005.00384.x","article-title":"The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.","volume":"68","author":"MH Heeg","year":"2005","journal-title":"Kidney Int"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/10799890903078465","article-title":"TGF-beta 1\/Smads signaling stimulates renal interstitial fibrosis in experimental AAN.","volume":"29","author":"J Li","year":"2009","journal-title":"J Recept Signal Transduct Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1046\/j.1523-1755.1999.00733.x","article-title":"TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression.","volume":"56","author":"T Hayashida","year":"1999","journal-title":"Kidney Int"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1046\/j.1523-1755.2001.00067.x","article-title":"Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.","volume":"60","author":"Y Uchiyama-Tanaka","year":"2001","journal-title":"Kidney Int"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","article-title":"cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.","volume":"57","author":"T Yamaguchi","year":"2000","journal-title":"Kidney Int"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype.","volume":"279","author":"T Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1681\/ASN.2004090800","article-title":"Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease.","volume":"17","author":"S Omori","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/diabetes.53.1.200","article-title":"Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.","volume":"53","author":"B Guo","year":"2004","journal-title":"Diabetes"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1096\/fj.03-0037fje","article-title":"Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.","volume":"17","author":"T Hayashida","year":"2003","journal-title":"FASEB J"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1681\/ASN.2005030257","article-title":"hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.","volume":"17","author":"Y Li","year":"2006","journal-title":"J Am Soc Nephrol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T16:50:09Z","timestamp":1639932609000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028915"}},"subtitle":[],"editor":[{"given":"Niels Olsen Saraiva","family":"C\u00e2mara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,9]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028915","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,9]]}}}